Steven Reichling's most recent trade in Accelerate Diagnostics Inc was a trade of 9,438 Employee Restricted Stock Units done . Disclosure was reported to the exchange on March 13, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 9,438 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 9,438 | 147,078 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.49 per share. | 13 Mar 2023 | 4,708 | 142,370 (0%) | 0% | 0.5 | 2,307 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 123,600 | 200,418 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2023 | 123,600 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 08 Mar 2023 | 62,778 | 137,640 (0%) | 0% | 0.5 | 29,506 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 123,600 | 123,600 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 9,439 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2023 | 9,439 | 81,641 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 13 Feb 2023 | 4,823 | 76,818 (0%) | 0% | 0.6 | 2,894 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 9,439 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jan 2023 | 9,439 | 76,932 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 13 Jan 2023 | 4,730 | 72,202 (0%) | 0% | 0.7 | 3,264 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.39 per share. | 22 Aug 2022 | 5,000 | 67,493 (0%) | 0% | 1.4 | 6,950 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 57,736 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Apr 2022 | 57,736 | 92,408 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 26 Apr 2022 | 29,915 | 62,493 (0%) | 0% | 1.0 | 29,317 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2022 | 190,299 | 190,299 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2022 | 57,736 | 57,736 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 27,392 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 May 2021 | 27,392 | 42,975 (0%) | 0% | - | Common Stock | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 12 May 2021 | 8,303 | 34,672 (0%) | 0% | 6.8 | 56,128 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 113,265 | 140,657 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 27,392 | 27,392 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 25,000 | 50,000 | - | - | Employee Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 25 Jan 2021 | 25,000 | 13,300 (0%) | 0% | 15.3 | 381,250 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 25 Jan 2021 | 25,000 | 38,300 (0%) | 0% | 3.0 | 74,500 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 24,910 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 25 Jan 2021 | 24,910 | 13,300 (0%) | 0% | 12.5 | 311,375 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 25 Jan 2021 | 24,910 | 38,210 (0%) | 0% | 3.0 | 74,232 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.55 per share. | 25 Jan 2021 | 20,761 | 13,300 (0%) | 0% | 10.6 | 219,029 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2021 | 20,761 | 99,910 | - | - | Employee Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 25 Jan 2021 | 20,761 | 34,061 (0%) | 0% | 3.0 | 61,868 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Nov 2020 | 39,329 | 120,671 | - | - | Employee Stock Option (right to buy) | |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 09 Nov 2020 | 39,329 | 13,300 (0%) | 0% | 9.5 | 373,626 | Common Stock |
| Accelerate Diagnostics Inc | Steven Reichling | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.98 per share. | 09 Nov 2020 | 39,329 | 52,629 (0%) | 0% | 3.0 | 117,200 | Common Stock |